MktsMarkets

ProKidney Corp.
NASDAQ: PROKKey statistics
PROK News
Stories mentioning PROK from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 33,842 | 34,157 | 26,821 | 25,882 | 27,263 | 39,781 | 31,250 | 29,404 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 45,159 | 45,596 | 38,756 | 39,930 | 41,618 | 51,647 | 48,973 | 43,056 |
| Operating Income (Loss) | (44,933) | (45,371) | (38,539) | (39,709) | (41,388) | (51,571) | (48,973) | (43,056) |
| Interest Income | ||||||||
| Interest Expense | 15.00 | 1.00 | 2.00 | 1.00 | 0.00 | 2.00 | 2.00 | 3.00 |
| Other Expense | ||||||||
| Pretax Income | (42,621) | (42,437) | (35,283) | (36,117) | (37,361) | (46,781) | (43,395) | (38,522) |
| Tax Provision | 0.00 | (1,585) | 560.00 | 848.00 | 591.00 | 1,702 | (2,342) | (56.00) |
| Net Income (Loss) | (20,037) | (19,231) | (16,469) | (16,552) | (16,734) | (21,278) | (17,910) | (12,506) |
| Earnings Per Share (Basic) | ||||||||
| Earnings Per Share (Diluted) | ||||||||
| Weighted Average Shares Outstanding (Basic) | ||||||||
| Weighted Average Shares Outstanding (Diluted) | ||||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PROK
ProKidney Corp. (NASDAQ: PROK) is a stock listed on the Nasdaq Stock Market under the ticker symbol PROK. It last traded at $1.04 (Nov 13, 2026, 9:30 AM ET), down 9.1% on the day. That gives ProKidney a market capitalisation of $316.0M.
Over the past 52 weeks PROK has traded between $0.8700 and $2.65.
For the quarter ended Mar 31, 2026 it reported a net loss of $20.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$20.0M |
| Dec 31, 2025 | — | -$19.2M |
| Sep 30, 2025 | — | -$16.5M |
| Jun 30, 2025 | — | -$16.6M |
From ProKidney’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…